Tore Duvold joined Innovation Fund Denmark (IFD) on 1 May 2015 as Executive Vice President, and was appointed interim Managing Director on 11 April 2019.
Tore has eighteen years’ experience from the pharmaceutical and biotech industry. In his career, Tore has been involved in the establishment of two biopharmaceutical companies and has been Senior Vice President and part of Executive Management at LEO Pharma, where he collaborated closely with universities and biotech companies. He has contributed to the development of several drug candidates and new products.
Tore Duvold’s educational background is organic chemistry from the universities of Oslo and Bergen and a PhD in bio-organic chemistry from Université Louis Pasteur. In addition, he has completed Executive Educations at IMD, Switzerland and INSEAD, France.